IRES-mediated translation of cellular messenger RNA operates in eIF2α-independent manner during stress

Nucleic Acids Research

Volumn 40, Issue 2, 2012, Pages 541-552

  Thakor, Nehal ^a   Holcik, Martin ^a,b  

^a CHILDREN S HOSPITAL OF EASTERN ONTARIO   (Canada)

^b UNIVERSITY OF OTTAWA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

INITIATION FACTOR 2ALPHA; MESSENGER RNA; X LINKED INHIBITOR OF APOPTOSIS;

ARTICLE; CELL STRESS; CELLULAR STRESS RESPONSE; COMPLEX FORMATION; CONTROLLED STUDY; GENE EXPRESSION PROFILING; GENE SWITCHING; IN VITRO STUDY; IN VIVO STUDY; INTERNAL RIBOSOME ENTRY SITE; NUCLEAR REPROGRAMMING; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN RNA BINDING; RNA TRANSLATION; WESTERN BLOTTING; X CHROMOSOME;

5' UNTRANSLATED REGIONS; EUKARYOTIC INITIATION FACTOR-2; EUKARYOTIC INITIATION FACTORS; HEK293 CELLS; HUMANS; PEPTIDE CHAIN INITIATION, TRANSLATIONAL; STRESS, PHYSIOLOGICAL; X-LINKED INHIBITOR OF APOPTOSIS PROTEIN;

EID: 84855863141     PISSN: 03051048     EISSN: 13624962     Source Type: Journal    
DOI: 10.1093/nar/gkr701     Document Type: Article

References (54)

1. Holcik, M. and Sonenberg, N. (2005) Translational control in stress and apoptosis. Nat. Rev. Mol. Cell. Biol., 6, 318-327.
2. Komar, A. A. and Hatzoglou, M. (2011) Cellular IRES-mediated translation: the war of ITAFs in pathophysiological states. Cell Cycle, 10, 229-240.
3. Silvera, D., Formenti, S. C. and Schneider, R. J. (2010) Translational control in cancer. Nat. Rev. Cancer, 10, 254-266.
4. Braunstein, S., Karpisheva, K., Pola, C., Goldberg, J., Hochman, T., Yee, H., Cangiarella, J., Arju, R., Formenti, S. C. and Schneider, R. J. (2007) A hypoxia-controlled cap-dependent to cap-independent translation switch in breast cancer. Mol. Cell, 28, 501-512.
5. Gebauer, F. and Hentze, M. W. (2004) Molecular mechanisms of translational control. Nat. Rev. Mol. Cell. Biol., 5, 827-835.
6. Ron, D. and Harding, H. P. (2007) eIF2α phosphorylation in cellular stress responses and disease. In Mathews, M. B., Sonenberg, N. and Hershey, J. W. B. (eds), Translational Control in Biology and Medicine. Cold Spring Harbor Laboratory Press, New York, pp. 345-368.
7. Warnakulasuriyarachchi, D., Cerquozzi, S., Cheung, H. H. and Holcik, M. (2004) Translational induction of the inhibitor of apoptosis protein HIAP2 during endoplasmic reticulum stress attenuates cell death and is mediated via an inducible internal ribosome entry site element. J. Biol. Chem., 279, 17148-17157.
8. Gu, L., Zhu, N., Zhang, H., Durden, D. L., Feng, Y. and Zhou, M. (2009) Regulation of XIAP translation and induction by MDM2 following irradiation. Cancer Cell, 15, 363-375.
9. Holcik, M., Yeh, C., Korneluk, R. G. and Chow, T. (2000) Translational upregulation of X-linked inhibitor of apoptosis (XIAP) increases resistance to radiation induced cell death. Oncogene, 19, 4174-4177.
10. Muaddi, H., Majumder, M., Peidis, P., Papadakis, A. I., Holcik, M., Scheuner, D., Kaufman, R. J., Hatzoglou, M. and Koromilas, A. E. (2010) Phosphorylation of eIF2alpha at serine 51 is an important determinant of cell survival and adaptation to glucose deficiency. Mol. Biol. Cell, 21, 3220-3231.
11. Riley, A., Jordan, L. E. and Holcik, M. (2010) Distinct 5′ UTRs regulate XIAP expression under normal growth conditions and during cellular stress. Nucleic Acids Res., 38, 4665-4674.
12. Liston, P., Fong, W. G. and Korneluk, R. G. (2003) The inhibitors of apoptosis: there is more to life than Bcl2. Oncogene, 22, 8568-8580.
13. Gyrd-Hansen, M. and Meier, P. (2010) IAPs: from caspase inhibitors to modulators of NF-kappaB, inflammation and cancer. Nat. Rev. Cancer, 10, 561-574.
14. Carter, B. Z., Mak, D. H., Morris, S. J., Borthakur, G., Estey, E., Byrd, A. L., Konopleva, M., Kantarjian, H. and Andreeff, M. (2011) XIAP antisense oligonucleotide (AEG35156) achieves target knockdown and induces apoptosis preferentially in CD34+38-cells in a phase 1/2 study of patients with relapsed/refractory AML. Apoptosis, 16, 67-74.
15. Dean, E., Jodrell, D., Connolly, K., Danson, S., Jolivet, J., Durkin, J., Morris, S., Jowle, D., Ward, T., Cummings, J. et al. (2009) Phase I trial of AEG35156 administered as a 7-day and 3-day continuous intravenous infusion in patients with advanced refractory cancer. J. Clin. Oncol., 27, 1660-1666.
16. Schimmer, A. D., Estey, E. H., Borthakur, G., Carter, B. Z., Schiller, G. J., Tallman, M. S., Altman, J. K., Karp, J. E., Kassis, J., Hedley, D. W. et al. (2009) Phase I/II trial of AEG35156 X-linked inhibitor of apoptosis protein antisense oligonucleotide combined with idarubicin and cytarabine in patients with relapsed or primary refractory acute myeloid leukemia. J. Clin. Oncol., 27, 4741-4746.
17. Tamm, I., Kornblau, S. M., Segall, H., Krajewski, S., Welsh, K., Kitada, S., Scudiero, D. A., Tudor, G., Qui, Y. H., Monks, A. et al. (2000) Expression and prognostic significance of IAP-family genes in human cancers and myeloid leukemias. Clin. Cancer Res., 6, 1796-1803.
18. Yamagiwa, Y., Marienfeld, C., Meng, F., Holcik, M. and Patel, T. (2004) Translational regulation of X-linked inhibitor of apoptosis protein by interleukin-6: a novel mechanism of tumor cell survival. Cancer Res., 64, 1293-1298.
19. Yoon, A., Peng, G., Brandenburger, Y., Zollo, O., Xu, W., Rego, E. and Ruggero, D. (2006) Impaired control of IRES-mediated translation in X-linked dyskeratosis congenita. Science, 312, 902-906.
20. Locker, N., Easton, L. E. and Lukavsky, P. J. (2006) Affinity purification of eukaryotic 48S initiation complexes. RNA, 12, 683-690.
21. Locker, N. and Lukavsky, P. J. (2007) A practical approach to isolate 48S complexes: affinity purification and analyses. Methods Enzymol., 429, 83-104.
22. Lukavsky, P. J. and Puglisi, J. D. (2004) Large-scale preparation and purification of polyacrylamide-free RNA oligonucleotides. RNA, 10, 889-893.
23. Li, J., Feng, Q., Kim, J. M., Schneiderman, D., Liston, P., Li, M., Vanderhyden, B., Faught, W., Fung, M. F., Senterman, M. et al. (2001) Human ovarian cancer and cisplatin resistance: possible role of inhibitor of apoptosis proteins. Endocrinology, 142, 370-380.
24. Holcik, M., Lefebvre, C., Yeh, C., Chow, T. and Korneluk, R. G. (1999) A new internal-ribosome-entry-site motif potentiates XIAP-mediated cytoprotection. Nat. Cell. Biol., 1, 190-192.
25. Anthony, D. D. and Merrick, W. C. (1992) Analysis of 40 S and 80 S complexes with mRNA as measured by sucrose density gradients and primer extension inhibition. J. Biol. Chem., 267, 1554-1562.
26. Hartz, D., McPheeters, D. S., Traut, R. and Gold, L. (1988) Extension inhibition analysis of translation initiation complexes. Methods Enzymol., 164, 419-425.
27. Shirokikh, N. E., Alkalaeva, E. Z., Vassilenko, K. S., Afonina, Z. A., Alekhina, O. M., Kisselev, L. L. and Spirin, A. S. (2010) Quantitative analysis of ribosome-mRNA complexes at different translation stages. Nucleic Acids Res., 38, e15.
28. Thoma, C., Bergamini, G., Galy, B., Hundsdoerfer, P. and Hentze, M. W. (2004) Enhancement of IRES-mediated translation of the c-myc and BiP mRNAs by the poly (A) tail is independent of intact eIF4G and PABP. Mol. Cell, 15, 925-935.
29. Dmitriev, S. E., Pisarev, A. V., Rubtsova, M. P., Dunaevsky, Y. E. and Shatsky, I. N. (2003) Conversion of 48S translation preinitiation complexes into 80S initiation complexes as revealed by toeprinting. FEBS Lett., 533, 99-104.
30. Price, N. T., Welsh, G. I. and Proud, C. G. (1991) Phosphorylation of only serine-51 in protein synthesis initiation factor-2 is associated with inhibition of peptide-chain initiation in reticulocyte lysates. Biochem. Biophys. Res. Commun., 176, 993-999.
31. Pestova, T. V., de Breyne, S., Pisarev, A. V., Abaeva, I. S. and Hellen, C. U. (2008) eIF2-dependent and eIF2-independent modes of initiation on the CSFV IRES: a common role of domain II. EMBO J., 27, 1060-1072.
32. Terenin, I. M., Dmitriev, S. E., Andreev, D. E. and Shatsky, I. N. (2008) Eukaryotic translation initiation machinery can operate in a bacterial-like mode without eIF2. Nat. Struct. Mol. Biol., 15, 836-841.
33. Fringer, J. M., Acker, M. G., Fekete, C. A., Lorsch, J. R. and Dever, T. E. (2007) Coupled release of eukaryotic translation initiation factors 5B and 1A from 80S ribosomes following subunit joining. Mol. Cell. Biol., 27, 2384-2397.
34. Holcik, M. and Korneluk, R. G. (2001) XIAP, the guardian angel. Nat. Rev. Mol. Cell. Biol., 2, 550-556.
35. Bevilacqua, E., Wang, X., Majumder, M., Gaccioli, F., Yuan, C. L., Wang, C., Zhu, X., Jordan, L. E., Scheuner, D., Kaufman, R. J. et al. (2010) eIF2alpha phosphorylation tips the balance to apoptosis during osmotic stress. J. Biol. Chem., 285, 17098-17111.
36. Baranick, B. T., Lemp, N. A., Nagashima, J., Hiraoka, K., Kasahara, N. and Logg, C. R. (2008) Splicing mediates the activity of four putative cellular internal ribosome entry sites. Proc. Natl Acad. Sci. USA, 105, 4733-4738.
37. Saffran, H. A. and Smiley, J. R. (2009) The XIAP IRES activates 3′ cistron expression by inducing production of monocistronic mRNA in the betagal/CAT bicistronic reporter system. RNA, 15, 1980-1985.
38. Silvera, D., Arju, R., Darvishian, F., Levine, P. H., Zolfaghari, L., Goldberg, J., Hochman, T., Formenti, S. C. and Schneider, R. J. (2009) Essential role for eIF4GI overexpression in the pathogenesis of inflammatory breast cancer. Nat. Cell. Biol., 11, 903-908.
39. Silvera, D. and Schneider, R. J. (2009) Inflammatory breast cancer cells are constitutively adapted to hypoxia. Cell Cycle, 8, 3091-3096.
40. Aird, K. M., Ding, X., Baras, A., Wei, J., Morse, M. A., Clay, T., Lyerly, H. K. and Devi, G. R. (2008) Trastuzumab signaling in ErbB2-overexpressing inflammatory breast cancer correlates with X-linked inhibitor of apoptosis protein expression. Mol. Cancer Ther., 7, 38-47.
41. Aird, K. M., Ghanayem, R. B., Peplinski, S., Lyerly, H. K. and Devi, G. R. (2010) X-linked inhibitor of apoptosis protein inhibits apoptosis in inflammatory breast cancer cells with acquired resistance to an ErbB1/2 tyrosine kinase inhibitor. Mol. Cancer Ther., 9, 1432-1442.
42. Shi, Z., Liang, Y. J., Chen, Z. S., Wang, X. H., Ding, Y., Chen, L. M. and Fu, L. W. (2007) Overexpression of Survivin and XIAP in MDR cancer cells unrelated to P-glycoprotein. Oncol Rep., 17, 969-976.
43. Kim, S. H., Forman, A. P., Mathews, M. B. and Gunnery, S. (2000) Human breast cancer cells contain elevated levels and activity of the protein kinase, PKR. Oncogene, 19, 3086-3094.
44. Dmitriev, S. E., Terenin, I. M., Andreev, D. E., Ivanov, P. A., Dunaevsky, J. E., Merrick, W. C. and Shatsky, I. N. (2010) GTP-independent tRNA delivery to the ribosomal P-site by a novel eukaryotic translation factor. J. Biol. Chem., 285, 26779-26787.
45. Skabkin, M. A., Skabkina, O. V., Dhote, V., Komar, A. A., Hellen, C. U. and Pestova, T. V. (2010) Activities of ligatin and MCT-1/DENR in eukaryotic translation initiation and ribosomal recycling. Genes Dev., 24, 1787-1801.
46. Carter, B. Z., Gronda, M., Wang, Z., Welsh, K., Pinilla, C., Andreeff, M., Schober, W. D., Nefzi, A., Pond, G. R., Mawji, I. A. et al. (2005) Small-molecule XIAP inhibitors derepress downstream effector caspases and induce apoptosis of acute myeloid leukemia cells. Blood, 105, 4043-4050.
47. LaCasse, E. C., Mahoney, D. J., Cheung, H. H., Plenchette, S., Baird, S. and Korneluk, R. G. (2008) IAP-targeted therapies for cancer. Oncogene, 27, 6252-6275.
48. Pardo, O. E., Lesay, A., Arcaro, A., Lopes, R., Ng, B. L., Warne, P. H., McNeish, I. A., Tetley, T. D., Lemoine, N. R., Mehmet, H. et al. (2003) Fibroblast growth factor 2-mediated translational control of IAPs blocks mitochondrial release of Smac/DIABLO and apoptosis in small cell lung cancer cells. Mol. Cell. Biol., 23, 7600-7610.
49. Schimmer, A. D., Welsh, K., Pinilla, C., Wang, Z., Krajewska, M., Bonneau, M. J., Pedersen, I. M., Kitada, S., Scott, F. L., Bailly-Maitre, B. et al. (2004) Small-molecule antagonists of apoptosis suppressor XIAP exhibit broad antitumor activity. Cancer Cell, 5, 25-35.
50. Flygare, J. A. and Fairbrother, W. J. (2010) Small-molecule pan-IAP antagonists: a patent review. Expert. Opin. Ther. Pat., 20, 251-267.
51. Marsh, R. A., Madden, L., Kitchen, B. J., Mody, R., McClimon, B., Jordan, M. B., Bleesing, J. J., Zhang, K. and Filipovich, A. H. (2010) XIAP deficiency: a unique primary immunodeficiency best classified as X-linked familial hemophagocytic lymphohistiocytosis and not as X-linked lymphoproliferative disease. Blood, 116, 1079-1082.
52. Rigaud, S., Fondaneche, M. C., Lambert, N., Pasquier, B., Mateo, V., Soulas, P., Galicier, L., Le Deist, F., Rieux-Laucat, F., Revy, P. et al. (2006) XIAP deficiency in humans causes an X-linked lymphoproliferative syndrome. Nature, 444, 110-114.
53. Schneider, R. J. and Sonenberg, N. (2007) Translational control in cancer development and progression. In Mathews, M. B., Sonenberg, N. and Hershey, J. W. B. (eds), Translational Control in Biology and Medicine. Cold Spring Harbor Laboratory Press, New York, pp. 401-431.
54. Baird, S. D., Lewis, S. M., Turcotte, M. and Holcik, M. (2007) A search for structurally similar cellular internal ribosome entry sites. Nucleic Acids Res., 35, 4664-4677.